Percutaneous Closure Step by Step: How a Catheter Seals an Atrial Septal Defect or PFO

The echo technician goes quiet for a moment, adjusts the probe, and asks you to hold your breath. Later, in a smaller room, a cardiologist draws two boxes on a notepad, a wall between them, and a gap in that wall. You have had it since before you were born. Nobody noticed until now.

That sketch is the beginning of a very common conversation, and the question that follows is almost always the same: how percutaneous ASD closure is done, and whether it really means no open-heart surgery. The short version is that a device the size of a coin travels through a vein, unfolds on either side of the hole, and stays there for life. The longer version deserves more than a notepad.

This explainer walks through the whole thing: who is offered it, what happens in the room, what the first weeks feel like, and where the evidence is firm or still thin.

What is an atrial septal defect, and how is a PFO different?

The heart has four chambers. The two upper ones, the atria, are separated by a thin muscular wall called the atrial septum. An atrial septal defect (ASD) is a true hole in that wall, present from birth, because the tissue never fully formed. A patent foramen ovale (PFO) is different in a way that matters for treatment: it is not a missing patch of wall but a flap that failed to seal.

Every fetus has that flap. Before birth, the lungs are not yet in use, so blood is routed straight from the right atrium to the left through an opening called the foramen ovale. After the first breaths, pressure changes push the flap shut, and in most people it fuses within the first year or two. In roughly one in four adults it never fuses completely, according to Mayo Clinic, which means a PFO is common enough to count as a variant rather than a disease.

A true ASD is rarer. The CDC estimates that about 1 in every 1,859 babies born in the United States each year has one. Because the left atrium works at higher pressure than the right, blood leaks left to right through the hole; clinicians call this a shunt. Small shunts cause no trouble. Larger ones send extra blood through the right side of the heart and the lungs, year after year, and the right chambers slowly stretch. That stretching, not the hole itself, is why adults with an undiagnosed ASD may develop breathlessness, palpitations, or fatigue in their thirties and forties, as the NHS and Mayo Clinic both describe.

A PFO usually causes no shunt worth measuring. Its clinical importance is almost entirely about one scenario: a clot from a leg or pelvic vein slipping through the flap to the brain, which is one proposed mechanism for strokes with no other identified cause in younger adults.

How percutaneous ASD closure is done, in plain language

Percutaneous simply means “through the skin.” Instead of opening the chest, the cardiologist reaches the heart through the body’s own plumbing. A large vein at the top of the thigh, the femoral vein, runs almost directly up to the right atrium, so it is the natural entry route.

The closure device itself is easier to picture than to name. Imagine two tiny round umbrellas made of fine metal mesh, joined at the handles by a short waist. The mesh is woven from nitinol, a nickel-titanium alloy that remembers its shape: it can be squeezed into a tube narrower than a drinking straw, then springs back to its original form when pushed out. Inside each disc sit thin fabric patches that help block blood flow while the body’s own tissue grows over the frame.

Here is the sequence in one paragraph. A catheter, which is a thin flexible tube, is guided up the vein into the right atrium and across the defect into the left atrium. The hole is measured. A delivery tube of the right size follows the same path. The first disc is pushed out into the left atrium and opened. The whole system is drawn gently back until that disc sits flat against the left side of the septum. The waist fills the hole. The second disc opens on the right side. The two discs now clamp the wall like a snap fastener on a jacket. Once ultrasound confirms the device is stable and the leak has stopped, it is released from its cable and the catheter is withdrawn.

No incision beyond a needle puncture. No heart-lung machine. Mayo Clinic and Cleveland Clinic describe this transcatheter approach as the standard treatment for the most common type of ASD when the anatomy suits it, with most people going home the same day or the next morning. What determines whether the anatomy suits it comes next.

Who is usually offered catheter closure, and who is asked to wait?

Not every hole qualifies, and the selection step is arguably the most important part of the whole pathway. The device needs something to grip.

Catheter closure is used for the secundum type of ASD, the kind sitting in the middle of the septum, because it is surrounded by a rim of tissue on all sides for the discs to hold. Other types sit at the edges of the wall, near the heart valves or the great veins, and there is no rim to grip; these are repaired surgically, as Mayo Clinic and the NHS explain. A defect can also simply be too large for available devices. Sizing decisions rest with the treating team and the imaging.

Having the right shape is not the only criterion. Guideline-level practice, reflected in Mayo Clinic’s treatment overview, generally supports closure when the shunt is large enough to have enlarged the right heart or to cause symptoms. A small ASD that has caused no chamber enlargement and no symptoms may be watched with periodic echocardiograms rather than closed.

Some people are asked to wait, and some are advised against closure altogether:

• Young children with small defects, because many small ASDs close on their own in the first years of life; Mayo Clinic notes that closure is often deferred to preschool age or later unless the child is unwell.
• People with severe pulmonary hypertension, meaning very high pressure in the lung arteries, where closing the hole can worsen strain on the right heart; specialist assessment decides.
• People with an active infection, or with a known severe nickel allergy, where the team weighs alternatives.
• People who cannot take antiplatelet medicine in the months after the procedure for other medical reasons.

For PFO, the calculation is different again: the flap is closed not because of a shunt but because of a stroke, and only in a defined group. That deserves its own section below.

What tests come before the procedure?

The procedure is short. The planning is not, and most of it happens on ultrasound.

A standard echocardiogram, the ultrasound done through the chest wall, usually makes the diagnosis and shows whether the right heart has enlarged. It is not precise enough to plan a device, so nearly everyone has a transesophageal echocardiogram (TEE): a slim ultrasound probe is passed down the throat into the food pipe, which lies directly behind the heart, giving a much sharper picture of the septum. TEE is often done under sedation before the procedure and again during it. Some centers use intracardiac echocardiography (ICE) instead, a miniature ultrasound probe carried into the heart on its own catheter, as Cleveland Clinic describes.

What the imaging team is measuring:

• The diameter of the hole, often in two planes, because defects are rarely perfect circles.
• The rims: the width of tissue between the hole’s edge and the nearby valves and veins. Deficient rims raise the risk of a device rubbing against neighboring structures.
• The total length of the septum, since the discs must fit within it.
• The direction and volume of the shunt, and any second hole nearby.

Cardiac MRI or CT is sometimes added when the veins draining into the heart need clarifying. A right-heart catheterization, measuring pressures directly, may be done at the start of the same session, or beforehand if pulmonary hypertension is suspected.

Routine preparation includes an electrocardiogram, blood tests, a check of kidney function because contrast dye is used, and a review of every medicine you take, especially blood thinners. Expect to be asked about dental health: an infected tooth is a source of bacteria, and a fresh device is a place bacteria could settle. Fasting instructions and any medicine changes come from the team, and only from them.

The ASD device closure procedure step by step: what happens in the cath lab

The room is bright, cool, and busier than people expect. A cardiologist, an imaging specialist, a nurse or two, a radiographer, and often an anesthetist all have jobs to do.

Step one: comfort. Adults are often given sedation with a local anesthetic at the groin; general anesthesia is common when TEE is used throughout, and standard for children, as the NHS notes. You lie flat on a narrow table with an X-ray arm above you.

Step two: access. After numbing the skin at the top of the thigh, a needle enters the femoral vein and a short plastic sheath is placed, a kind of doorway that everything else passes through. Heparin, an anticoagulant, is given through the line to prevent clots forming on the equipment.

Step three: crossing. A soft guide wire and catheter travel up the vein, into the right atrium, and through the hole into the left atrium. Fluoroscopy, which is live X-ray, tracks their position. You may feel pressure or a flutter but usually not pain.

Step four: sizing. A soft balloon is inflated across the defect until the leak on ultrasound stops, and its waist is measured. This “stop-flow” diameter is what the device is chosen against.

Step five: deployment. The delivery sheath is advanced into the left atrium. The left disc opens, is drawn back to the septum, the waist expands in the hole, and the right disc opens. The operator pushes and pulls gently on the cable to confirm the device is anchored, and the echo team checks that neither disc leans on a valve or vein.

Step six: release and check. A final ultrasound looks for residual flow. The device is unscrewed from its cable, the catheters come out, and pressure or a stitch closes the puncture.

Cleveland Clinic and Mayo Clinic describe the procedure itself as commonly lasting one to two hours, with a few hours of lying flat afterward so the vein seals.

How does the device stay in place, and what happens to it over time?

People often assume something must be sewn or glued. Nothing is. The device holds because of geometry and material.

Nitinol has a property called superelasticity. Compressed inside the delivery tube it stores energy, and once freed it pushes outward to its designed shape. Each disc is sized larger than the hole, so the discs cannot pass back through, and the waist is chosen to match the stop-flow measurement so it sits snugly. The septum is sandwiched between two spring-loaded plates. The heart beats around it roughly 100,000 times a day from the first minute, which is exactly why the imaging team spends so long confirming the fit before release.

Within days, a thin layer of protein and cells coats the mesh. Over the following weeks, the heart’s own inner lining grows across both discs in a process called endothelialization. Cleveland Clinic describes the device as covered by the body’s tissue within about six months, at which point it is effectively part of the septum. The antiplatelet medicine prescribed after closure is there to protect against clots on the bare metal during this window; the timeline is the prescriber’s call.

A few practical consequences follow:

• You will not feel the device. It has no moving parts and no battery.
• Modern closure devices are generally labeled as MRI conditional, meaning scanning is permitted under specified conditions; your team provides an implant card with the details, and you should show it before any scan.
• Airport metal detectors are not a concern, though the card is useful to carry.
• The device does not need replacing and is not removed later.

Long-term follow-up continues because tissue healing cannot be seen from the outside. Echocardiograms in the first year confirm the discs have stayed put and the shunt has closed, and periodic checks after that watch heart rhythm and chamber size, as both Mayo Clinic and the NHS advise for anyone with a repaired congenital defect.

ASD closure vs open heart surgery: how the two approaches compare

Surgical repair has not gone away, and for some anatomies it remains the only option. In surgery, the chest is opened, the heart is stopped and supported by a heart-lung bypass machine, and the hole is stitched closed or covered with a patch of the patient’s own pericardium or synthetic material. Both routes aim at the same thing: no more shunt. The differences lie in access, recovery, and which defects each can handle.

Feature	Percutaneous (catheter) closure	Open surgical repair
Access	Needle puncture in groin vein	Incision through the breastbone or side of the chest
Heart-lung machine	Not used	Required
Anesthesia	Sedation or general	General
Defect types	Secundum ASD with adequate rims; PFO	All ASD types, very large defects, defects near valves or veins
Typical hospital stay	Same day or one night (Mayo Clinic, Cleveland Clinic)	Several days (NHS)
Return to usual activity	About a week for most people, with lifting limits (Cleveland Clinic)	Several weeks, with breastbone healing over roughly 6–8 weeks (NHS)
Visible scar	Essentially none	Chest scar
Device-specific risks	Embolization, erosion, nickel sensitivity	None
Surgery-specific risks	None	Wound infection, bleeding, effects of bypass

The table reads as if the catheter wins, and for a mid-septum hole of suitable size it usually is the first choice, which is why Mayo Clinic lists it as the standard approach for secundum defects. Read the middle row again, though. Anatomy decides, not preference. A person whose defect sits against the mitral valve, or whose rims are too thin to grip, is not a candidate for a device, and a surgeon closing that hole is giving them the right treatment rather than an outdated one.

Both approaches carry a small risk of rhythm disturbance afterward, and both need lifelong occasional follow-up. Where a choice genuinely exists, it should be made with a team that offers both.

What does PFO closure for stroke involve, and how is it different?

Mechanically, closing a PFO looks almost identical to closing an ASD: same vein, same route, a two-disc device, often smaller and with a thinner waist because there is a flap to pin rather than a gap to fill. The reasoning behind it is completely different, and the reasoning is where patients deserve candor.

A PFO in someone who has never had a stroke is, in nearly all cases, left alone. Mayo Clinic is explicit that most people with a PFO need no treatment. The question arises after a stroke or transient ischemic attack (a brief stroke-like episode) in which the usual causes have been searched for and not found. In that setting, the theory is paradoxical embolism: a clot from the veins crosses the flap and reaches the brain instead of being filtered out by the lungs.

Randomized trials tested whether closing the flap prevents another stroke better than medicine alone. The 2021 AHA/ASA guideline on secondary stroke prevention, drawing on those trials, states that in patients aged roughly 18 to 60 with a nonlacunar stroke of undetermined cause and a PFO with high-risk features, closure is reasonable after shared decision-making, and it describes the benefit as modest with a small increase in atrial fibrillation after the procedure. Outside that group, in older adults, in people with another plausible cause, or in lacunar strokes caused by small-vessel disease, the evidence does not support closure.

Two things follow. First, the decision is a neurology and cardiology conversation together, not a cardiology one alone. Second, the imaging matters as much as for an ASD: features such as a large flap opening or a floppy, redundant septum shift the balance, and the team will weigh them.

Migraine deserves a sentence because the question always comes up. PFO is more common in people with migraine with aura, and closure has been studied for it. Mayo Clinic notes the trials have not shown a clear benefit, and guideline bodies do not recommend closure for migraine alone.

Transcatheter ASD closure risks: what can go wrong, honestly

Percutaneous closure is described by Mayo Clinic and Cleveland Clinic as a generally safe procedure, and most people have no complication at all. “Generally safe” is not “risk-free,” and a good consent conversation names the specific problems rather than waving at them.

At the groin. Bruising is common and harmless. Less often, blood collects under the skin or the vein is damaged, occasionally needing a stitch or a longer stay.

Heart rhythm. The device sits close to the heart’s electrical wiring. Extra beats and palpitations are common in the first weeks and usually settle. Atrial fibrillation, an irregular fast rhythm, can appear after closure, particularly PFO closure, and is usually temporary; the AHA/ASA guideline flags it as the main procedural downside.

Device movement. Rarely, a device slips out of position, most often within the first day, which is one reason for the follow-up echo before discharge. A displaced device can often be retrieved with a catheter but sometimes requires surgery.

Erosion. This is the rare complication clinicians worry about most: the edge of a disc wearing through the atrial wall or the aorta over time, causing bleeding into the sac around the heart. It is linked to oversized devices and thin rims, which is exactly why sizing is done so carefully.

Clot and infection. A clot can form on the bare device before tissue covers it; antiplatelet medicine is prescribed to limit this. Infection on the device, called endocarditis, is rare but serious, which is why dental precautions are advised while it heals over.

Other. Air bubbles entering the circulation, allergic reaction to contrast dye or to nickel, a small residual leak, and X-ray exposure, which teams keep as low as possible.

The alternatives are surgical repair, medicine alone in the case of PFO, or watchful waiting for small defects. Each has its own risk column. Weighing them is the treating team’s job, done with you.

PFO closure recovery time and the first weeks after ASD closure

Recovery from catheter closure is short compared with almost any other heart procedure, but it is not nothing, and knowing the shape of it helps.

The first hours. You lie flat for a few hours so the vein puncture seals; sitting up too early can restart bleeding. Nurses check the groin, pulse, and blood pressure repeatedly. An echocardiogram and an electrocardiogram before discharge confirm the device is stable and the rhythm is steady. Mayo Clinic and Cleveland Clinic describe discharge the same day or after one night as typical.

Days one to seven. A bruise at the groin is normal and fades over a week or two. Keep the puncture site clean and dry; showering is usually fine after a day, soaking is not. Walking is encouraged from the first day. Driving is often paused for a few days after sedation and while the groin heals, on the team’s advice. Many people notice occasional skipped beats or fluttering; a short-lived rhythm disturbance in this window is well recognized. Chest discomfort that is sharp, worsens on lying flat, or comes with fever is not normal, and the red-flag section below applies.

Weeks one to four. Cleveland Clinic notes that most people return to ordinary activity, including desk work, within about a week. Heavy lifting, straining, and contact sports are usually held back for a period the team specifies, commonly a couple of weeks, to protect the groin and let the device bed in.

Months one to twelve. Follow-up echocardiograms are typically scheduled across the first year, often around one month, six months, and twelve months, to document that tissue has covered the device and the shunt has gone. Antiplatelet medicine continues for the period the prescriber sets, commonly around six months per Cleveland Clinic. Dental antibiotic precautions apply during this healing window.

Beyond a year, most people need only occasional cardiology review. Breathlessness that was caused by a large ASD often improves over months as the right heart remodels, though how much depends on how long the heart was overloaded.

Which medicines follow closure, what they do, and for how long?

The medicine list after percutaneous closure is short, and each item has a clear job. None of this is a recommendation; the specifics belong to the prescribing clinician.

Antiplatelet medicine. Platelets are the blood cells that clump to form clots, and bare metal is a surface they like. Aspirin and related antiplatelet drugs make platelets less sticky, lowering the chance of a clot forming on the device before the heart’s lining grows over it. Cleveland Clinic describes antiplatelet treatment continuing for roughly six months after ASD closure, which matches the endothelialization timeline. Some teams use two antiplatelet agents for the first weeks or months, particularly after PFO closure; others use one. Stopping early on your own is the one thing every guideline source warns against, because the risk it protects against is silent until it is not.

Anticoagulants. Some people were already taking a blood thinner for another reason, such as a prior clot or atrial fibrillation. Whether that continues, and whether an antiplatelet is added or substituted, is a judgment about bleeding versus clotting risk that only the prescriber can make with your full history.

Antibiotics before dental work. Bacteria enter the bloodstream during dental procedures that cause bleeding. While the device is still uncovered, it offers a surface they could colonize, causing endocarditis. Mayo Clinic and Cleveland Clinic note that antibiotic prophylaxis before certain dental procedures is generally advised for the first months after device placement, commonly about six months, after which the covered device is no longer considered a special risk. Tell your dentist about the device and the date it was placed.

Rhythm medicine. If atrial fibrillation appears, a short course of rate- or rhythm-controlling medicine may be used while it settles, alongside a discussion about clot prevention.

Anything you were taking for blood pressure, cholesterol, or diabetes usually continues unchanged. Bring an up-to-date list to every follow-up.

How is percutaneous ASD closure done in children?

Children are the largest group having this procedure, because a true ASD is most often found in childhood, sometimes by a murmur at a routine check, sometimes on an echo done for another reason.

The waiting period is deliberate. Mayo Clinic notes that many small ASDs close spontaneously in the first years of life. Unless a child is breathless, failing to gain weight, or showing right-heart enlargement, cardiologists commonly watch with echocardiograms and revisit the decision around preschool age, when the child is larger and the veins can comfortably accept the equipment. A device is chosen to fit the hole at that time; the septum grows around it afterward.

Preparation. Children have the procedure under general anesthesia, as the NHS describes for congenital heart catheterizations. Fasting instructions are given in hours and are age-specific. Many pediatric units have play specialists or child-life staff who use dolls and picture stories to explain the mask, the sticky ECG dots, and the “tiny tube in the leg.” Parents can usually stay until the anesthetic takes effect and be present when the child wakes.

On the day and after. The steps mirror the adult procedure, with TEE guidance throughout. The child lies flat for a few hours afterward, which is often the hardest part for a wriggly four-year-old; tablets, books, and a parent’s lap help. Most children go home the same day or the next morning. A dressing covers the groin for a day or two. Gentle play resumes quickly; climbing frames, trampolines, and rough sports are paused for the period the team sets. School is usually possible within about a week.

Follow-up. Echocardiograms over the first year check the device, and children remain under congenital cardiology review into adulthood. The NHS emphasizes this transition, because adults who lose touch with follow-up are the ones in whom late rhythm problems go unnoticed. Comfort measures and any medicines for children are directed entirely by the pediatric team.

What people often get wrong about ASD and PFO closure

Cardiology waiting rooms run on secondhand information. Some of it is out of date, and some was never true.

“A hole in the heart is an emergency.” Almost never. Many ASDs are found in adults who have felt fine for decades. Closure is planned, sometimes months ahead, because the damage a shunt does is slow. A PFO is a variant found in about a quarter of adults, per Mayo Clinic, and needs no action in most of them.

“If I have a PFO, it should be closed to prevent a stroke.” The evidence supports closure only in a specific group: people who have already had an otherwise unexplained stroke, broadly aged 18 to 60, after neurology and cardiology assessment, as the AHA/ASA guideline sets out. Preventive closure in people who have never had a stroke is not supported.

“Closure will treat my migraines.” Trials have not shown a clear benefit, and no major guideline recommends it for migraine.

“The device will be removed later.” It is permanent, and within months it is covered by the heart’s own tissue. Removal would require surgery and is done only for a serious complication.

“The device can fall out years later.” Displacement, when it happens, is almost always within the first day, before tissue growth begins. That is what the pre-discharge echo is for.

“Once it’s closed, I’m done with cardiologists.” Follow-up is lighter after the first year but does not end. Rhythm changes and, rarely, late complications are the reasons.

“Open-heart surgery for an ASD is old-fashioned.” Surgery is the correct treatment for defects the device cannot grip. Anatomy, not fashion, decides.

“I’ll feel the metal.” You will not. Palpitations in the first weeks are the heart’s electrical system reacting to a new neighbor, not the device moving.

“Children should have it done as early as possible.” Waiting for spontaneous closure and for growth is standard practice, not neglect.

Questions to ask your care team before percutaneous closure

A good consultation leaves you with fewer questions than you arrived with. This list is a starting point; take it in, cross out what has been answered, and add your own.

About the diagnosis

• Which type of defect do I have, and is it a shape and size a device can hold?
• Has my right heart enlarged, and by how much?
• Are my lung artery pressures normal?
• If this is a PFO after a stroke, has the neurology team agreed that closure is reasonable for me specifically, and what other causes have been excluded?

About the procedure

• Will I have sedation or general anesthesia, and why that choice?
• Will you use transesophageal or intracardiac echo to guide the device?
• What happens if the device does not fit well on the day?
• Would surgery be an option for me, and what would tip the decision toward it?

About afterward

• How long will I be in hospital, and who collects me?
• Which of my current medicines change before and after, and who manages that?
• How long will I take antiplatelet medicine, and what should I do if I miss a dose or start bleeding?
• What activity limits apply, for how long, and what about driving and work?
• When are my follow-up echoes, and what are you looking for at each?
• What should I tell my dentist, and for how long?
• Do I need an implant card for MRI scans?

About risks

• What complications do you specifically watch for in my anatomy?
• What symptoms should make me call, and which should send me to an emergency department?

Write the answers down or ask permission to record them. The details about medicine duration and activity limits are the ones people most often misremember, and they are the ones that matter in the weeks that follow.

When to call your doctor after ASD or PFO closure

Most people leave hospital with a bruise and a follow-up appointment and never need this section. Keep it anyway, because the rare problems after closure are time-sensitive.

Call emergency services immediately for any of the following, whatever the hour:

• Sudden weakness or numbness of the face, arm, or leg, especially on one side; slurred speech or trouble understanding; sudden loss of vision or balance. These are stroke signs, and a clot on a new device is one possible cause.
• Chest pain that is severe, crushing, or spreading to the arm, neck, or jaw.
• Fainting or near-fainting.
• Sudden severe breathlessness.
• Rapid swelling at the groin that keeps growing, or bleeding that does not stop after ten minutes of firm pressure.

Call your cardiology team the same day for:

• Fever, chills, or night sweats in the weeks after the procedure, which can signal infection on the device or at the puncture site.
• Palpitations that are sustained, very fast, or make you lightheaded, rather than brief flutters.
• Sharp chest pain that worsens when lying flat or breathing in, which can indicate irritation or fluid around the heart.
• Pain, swelling, or warmth in one leg, which may indicate a clot in the vein.
• Redness, warmth, or discharge at the groin site.
• A rash or itching that develops in the weeks after placement, which may suggest nickel sensitivity.

Mention at your next appointment a bruise that is slow to fade, mild occasional skipped beats, or tiredness in the first weeks. These are common and usually settle.

Do not stop antiplatelet medicine because of minor bruising or a nosebleed without speaking to the prescriber first; they will weigh the bleeding against the reason the medicine was started. Every decision about the device, your medicines, and your activity sits with the treating team, and they would far rather hear from you about a symptom that turns out to be nothing than not hear about one that was not.

Frequently asked questions

How is percutaneous ASD closure done, in one paragraph?

A thin catheter enters a vein at the top of the thigh, travels up to the right atrium and through the hole into the left atrium. The defect is measured with a soft balloon and ultrasound, then a folding nitinol mesh device is delivered through a tube: one disc opens on the left side, the waist fills the hole, the second disc opens on the right. Once imaging confirms a stable fit and no leak, the device is released and the catheter withdrawn.

What does the ASD device closure procedure feel like while it is happening?

Most adults feel very little. The groin is numbed with local anesthetic, and sedation or general anesthesia keeps you comfortable, particularly if a transesophageal echo probe is used throughout. Some people notice pressure at the groin, a fluttering sensation as catheters pass through the heart, or a warm flush from contrast dye. Pain is unusual and should be mentioned to the team immediately if it occurs.

What is the typical PFO closure recovery time?

Short, compared with other heart procedures. Cleveland Clinic and Mayo Clinic describe discharge the same day or after one night, a few hours of lying flat first, and a return to ordinary activity for most people within about a week. Heavy lifting and contact sports are paused for a period the team specifies. Follow-up echocardiograms across the first year and antiplatelet medicine for the prescribed months complete the recovery, with occasional palpitations common early on.

What are the main transcatheter ASD closure risks I should know about?

Groin bruising or bleeding, temporary heart rhythm disturbances including atrial fibrillation, and, rarely, device displacement, clot on the device, infection, or erosion of the heart wall by a disc edge. Allergic reactions to contrast dye or nickel and a small residual leak are also possible. Mayo Clinic and Cleveland Clinic describe the procedure as generally safe, but your team will explain which risks apply most to your anatomy.

How does ASD closure vs open heart surgery compare for recovery?

Catheter closure involves a needle puncture, no heart-lung machine, a stay of one night or less, and a return to normal activity in about a week according to Cleveland Clinic. Surgical repair involves a chest incision, bypass, several days in hospital, and weeks of recovery while the breastbone heals, per the NHS. Surgery remains the correct option for defects a device cannot grip, so the comparison only applies when both are anatomically possible.

Will I need to take blood thinners for life after closure?

Usually not because of the device alone. Antiplatelet medicine is typically prescribed for around six months while the heart’s lining grows over the mesh, as Cleveland Clinic describes, then stopped if there is no other reason to continue. People who already take an anticoagulant for another condition, or who develop atrial fibrillation afterward, may continue longer. The duration and any changes are decided by the prescribing clinician.

Can the closure device move or fall out years later?

Displacement is rare and, when it occurs, almost always happens within the first day, before the body’s tissue begins to grow over the device. That is why an echocardiogram is done before you leave hospital. Once endothelialization is complete, typically within about six months, the device is incorporated into the septum and is not expected to move. Follow-up echoes in the first year confirm this.

Is it safe to have an MRI scan with an ASD or PFO closure device?

Modern closure devices are generally labeled MRI conditional, meaning scans can be performed under specified conditions such as scanner strength. Your team will give you an implant card listing the device and its conditions; show it to any radiology department before a scan. Airport security scanners are not a concern. If you are unsure about your specific device, ask your cardiology team before booking imaging.

Should a PFO be closed to prevent a first stroke or to help migraines?

Current evidence does not support either. The AHA/ASA guideline supports PFO closure only in people roughly 18 to 60 who have already had a nonlacunar stroke of undetermined cause, after joint neurology and cardiology assessment. Trials of closure for migraine have not shown a clear benefit, and Mayo Clinic notes that most people with a PFO need no treatment at all.

How long do children with an ASD usually wait before closure?

Often until preschool age or later, unless the child is unwell. Mayo Clinic notes that many small ASDs close on their own in the first years of life, and waiting also allows the child to grow large enough for the catheter equipment to pass comfortably through the veins. A child who is breathless, growing poorly, or showing right-heart enlargement may be treated sooner. The pediatric cardiology team sets the timing.

References

• Cleveland Clinic: Atrial Septal Defect (ASD)
• CDC: About Atrial Septal Defect
• NHS: Congenital heart disease, treatment

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.